{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:05:06Z","timestamp":1763791506819,"version":"3.45.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["21JR7RA416"],"award-info":[{"award-number":["21JR7RA416"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10735-025-10540-1","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:29:20Z","timestamp":1762788560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Significance of pathological changes and chemokine expression in various organs in a Graves\u2019 disease animal model"],"prefix":"10.1007","volume":"56","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"5","key":"10540_CR1","doi-asserted-by":"publisher","DOI":"10.1530\/EC-24-0698","volume":"14","author":"S Abbaszadeh","year":"2025","unstructured":"Abbaszadeh S, Lundqvist MH, Ljunggren \u00d6 et al (2025) Estimation of kidney function in Graves\u2019 disease using creatinine and cystatin C. Endocr Connect 14(5):e240698","journal-title":"Endocr Connect"},{"issue":"1","key":"10540_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12020-013-9933-y","volume":"45","author":"K Agbaht","year":"2014","unstructured":"Agbaht K, Gullu S (2014) Adrenocortical reserves in hyperthyroidism. Endocrine 45(1):136\u2013143","journal-title":"Endocrine"},{"issue":"6","key":"10540_CR3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/15548627.2021.1985257","volume":"18","author":"P Ahuja","year":"2022","unstructured":"Ahuja P, Ng CF, Pang BPS et al (2022) Muscle-generated BDNF (brain derived neurotrophic factor) maintains mitochondrial quality control in female mice. Autophagy 18(6):1367\u20131384","journal-title":"Autophagy"},{"key":"10540_CR4","doi-asserted-by":"publisher","first-page":"1084068","DOI":"10.3389\/fcell.2023.1084068","volume":"11","author":"AB Andre","year":"2023","unstructured":"Andre AB, Rees KP, O\u2019Connor S et al (2023) Single cell analysis reveals satellite cell heterogeneity for proinflammatory chemokine expression. Front Cell Dev Biol 11:1084068","journal-title":"Front Cell Dev Biol"},{"key":"10540_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, Ferrari SM, Corrado A et al (2015) Autoimmune thyroid disorders. Autoimmun Rev 14:174\u2013180","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10540_CR6","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.4049\/jimmunol.170.12.6320","volume":"170","author":"M-P Armengol","year":"2003","unstructured":"Armengol M-P, Cardoso-Schmidt CB, Fern\u00e1ndez M et al (2003) Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J Immunol 170(12):6320\u20136328","journal-title":"J Immunol"},{"issue":"1","key":"10540_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.surg.2021.04.045","volume":"171","author":"JJ Baechle","year":"2022","unstructured":"Baechle JJ, Hanna DN, Sekhar KR et al (2022) Multiplatform computational analysis of mast cells in adrenocortical carcinoma tumor microenvironment. Surgery 171(1):111\u2013118","journal-title":"Surgery"},{"issue":"2","key":"10540_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0272-6386(99)70314-8","volume":"33","author":"BA Becker","year":"1999","unstructured":"Becker BA, Fenves AZ, Breslau NA (1999) Membranous glomerulonephritis associated with Graves\u2019 disease. Am J Kidney Dis 33(2):369\u2013373","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10540_CR9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11154-022-09713-0","volume":"23","author":"A Bekiaridou","year":"2022","unstructured":"Bekiaridou A, Kartas A, Moysidis DV et al (2022) The bidirectional relationship of thyroid disease and atrial fibrillation: established knowledge and future considerations. Rev Endocr Metab Disord 23(3):621\u2013630","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"10540_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.121.17712","volume":"79","author":"B Bonnard","year":"2022","unstructured":"Bonnard B, Ibarrola J, Lima-Posada I et al (2022) Neutrophil gelatinase-associated lipocalin from macrophages plays a critical role in renal fibrosis via the CCL5 (Chemokine Ligand 5)-Th2 cells-IL4 (Interleukin 4) pathway. Hypertension 79(2):352\u2013364","journal-title":"Hypertension"},{"key":"10540_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI0215745","volume":"110","author":"GD Chazenbalk","year":"2002","unstructured":"Chazenbalk GD, Pichurin P, Chen CR et al (2002) Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest 110:209\u2013217","journal-title":"J Clin Invest"},{"key":"10540_CR12","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1172\/JCI200317069","volume":"111","author":"CR Chen","year":"2003","unstructured":"Chen CR, Pichurin P, Nagayama Y et al (2003) The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J Clin Invest 111:1897\u20131904","journal-title":"J Clin Invest"},{"issue":"2","key":"10540_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3803\/EnM.2021.1333","volume":"37","author":"YY Cho","year":"2022","unstructured":"Cho YY, Kim B, Shin DW et al (2022) Graves\u2019 disease and the risk of end-stage renal disease: a Korean population-based study. Endocrinol Metab (Seoul) 37(2):281\u2013289","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"12","key":"10540_CR14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s40618-014-0157-7","volume":"37","author":"DM Costa","year":"2014","unstructured":"Costa DM, Mangano FA, Betterle C (2014) Thymic hyperplasia in patients with Graves\u2019 disease. J Endocrinol Invest 37(12):1175\u20131179","journal-title":"J Endocrinol Invest"},{"key":"10540_CR15","doi-asserted-by":"publisher","first-page":"1111960","DOI":"10.3389\/fimmu.2023.1111960","volume":"14","author":"KS Crawford","year":"2023","unstructured":"Crawford KS, Volkman BF (2023) Prospects for targeting ACKR1 in cancer and other diseases. Front Immunol 14:1111960","journal-title":"Front Immunol"},{"issue":"6","key":"10540_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1089\/thy.1997.7.879","volume":"7","author":"CM Dutton","year":"1997","unstructured":"Dutton CM, Joba W, Spitzweg C et al (1997) Thyrotropin receptor expression in adrenal, kidney, and thymus. Thyroid 7(6):879\u2013884","journal-title":"Thyroid"},{"key":"10540_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.754386","volume":"12","author":"G Elia","year":"2021","unstructured":"Elia G, Fallahi P, Francesca Ragusa F (2021) Precision medicine in Graves\u2019 disease and ophthalmopathy. Front Pharmacol 12:754386","journal-title":"Front Pharmacol"},{"key":"10540_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.654473","volume":"12","author":"P Fallahi","year":"2021","unstructured":"Fallahi P, Ferrari MS, Elia G (2021) Cytokines as targets of novel therapies for Graves\u2019 ophthalmopathy. Front Endocrinol (Lausanne) 12:654473","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"14","key":"10540_CR19","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1167\/iovs.16-20199","volume":"57","author":"S Fang","year":"2016","unstructured":"Fang S, Huang Y, Zhong S et al (2016) IL-17A promotes RANTES expression, but not IL-16, in orbital fibroblasts via CD40-CD40L combination in thyroid-associated ophthalmopathy. Invest Ophthalmol vis Sci 57(14):6123\u20136133","journal-title":"Invest Ophthalmol vis Sci"},{"key":"10540_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/thy.2018.0326","volume":"29","author":"J Fassbender","year":"2019","unstructured":"Fassbender J, Holthoff HP, Li ZM et al (2019) Therapeutic effects of short cyclic and combined epitope peptides in a long-term model of graves\u2019 disease and orbitopathy. Thyroid 29:258\u2013267","journal-title":"Thyroid"},{"issue":"4","key":"10540_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1055\/s-0038-1676988","volume":"119","author":"S Gencer","year":"2019","unstructured":"Gencer S, Vorst EPC, Aslani M et al (2019) Atypical chemokine receptors in cardiovascular disease. Thromb Haemost 119(4):534\u2013541","journal-title":"Thromb Haemost"},{"key":"10540_CR22","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1210\/en.2005-1375","volume":"147","author":"AG Gianoukakis","year":"2006","unstructured":"Gianoukakis AG, Douglas SR, King SC et al (2006) Immunoglobulin G from patients with Graves\u2019 disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease. Endocrinology 147:1941\u20131949","journal-title":"Endocrinology"},{"issue":"5","key":"10540_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1089\/thy.2019.0634","volume":"30","author":"D Grove-Laugesen","year":"2020","unstructured":"Grove-Laugesen D, Cramon PK, Malmstroem S et al (2020) Effects of supplemental vitamin D on muscle performance and quality of life in Graves\u2019 disease: a randomized clinical trial. Thyroid 30(5):661\u2013671","journal-title":"Thyroid"},{"issue":"8","key":"10540_CR24","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1089\/thy.2017.0086","volume":"27","author":"U Haider","year":"2017","unstructured":"Haider U, Richards P, Gianoukakis AG (2017) Thymic hyperplasia associated with Graves\u2019 disease: pathophysiology and proposed management algorithm. Thyroid 27(8):994\u20131000","journal-title":"Thyroid"},{"key":"10540_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.20945\/2359-3997000000244","volume":"64","author":"K He","year":"2020","unstructured":"He K, Jiang P, Liu BL et al (2020a) Intrathyroid injection of dexamethasone inhibits Th2 cells in Graves\u2019 disease. Arch Endocrinol Metab 64:243\u2013250","journal-title":"Arch Endocrinol Metab"},{"key":"10540_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.154998","volume":"127","author":"M He","year":"2020","unstructured":"He M, Wang Y, Wang J et al (2020b) The potential markers involved in newly diagnosed Graves\u2019 disease and the development of active Graves\u2019 orbitopathy. Cytokine 127:154998","journal-title":"Cytokine"},{"issue":"4","key":"10540_CR27","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1210\/en.2014-1813","volume":"156","author":"H Holthoff","year":"2015","unstructured":"Holthoff H, Goebel S, Li Z et al (2015) Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves\u2019 disease, tachycardia, and cardiac hypertrophy. Endocrinology 156(4):1577\u20131589","journal-title":"Endocrinology"},{"key":"10540_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1530\/eje.1.01923","volume":"153","author":"EO Johnson","year":"2005","unstructured":"Johnson EO, Kamilaris TC, Calogero AE et al (2005) Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 153:177\u2013185","journal-title":"Eur J Endocrinol"},{"key":"10540_CR29","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1210\/endo-128-5-2567","volume":"128","author":"TC Kamilaris","year":"1991","unstructured":"Kamilaris TC, De Bold CR, Johnson EO et al (1991) Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone response to ovine corticotrophin-releasing hormone in rats. Endocrinol 128:2567\u20132576","journal-title":"Endocrinol"},{"issue":"3\u20135","key":"10540_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000180514","volume":"15","author":"AI Katz","year":"1975","unstructured":"Katz AI, Emmanouel DS, Lindheimer MD (1975) Thyroid hormone and the kidney. Nephron 15(3\u20135):223\u2013249","journal-title":"Nephron"},{"key":"10540_CR31","first-page":"81","volume":"16","author":"T Khongsaengbhak","year":"2024","unstructured":"Khongsaengbhak T, Atthakitmongkol T, Tanwandee T (2024) Liver dysfunction in hyperthyroidism. Hepat Med 16:81\u201389","journal-title":"Hepat Med"},{"key":"10540_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00086","volume":"8","author":"G Kleinau","year":"2017","unstructured":"Kleinau G, Worth CL, Kreuchwig A et al (2017) Structural-functional features of the thyrotropin receptor: a class A G-protein-coupled receptor at work. Front Endocrinol (Lausanne) 8:86","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10540_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM200102153440707","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344(7):501\u2013509","journal-title":"N Engl J Med"},{"issue":"11","key":"10540_CR34","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41574-024-01016-5","volume":"20","author":"G Lanzolla","year":"2024","unstructured":"Lanzolla G, Marin\u00f2 M, Menconi F (2024) Graves disease: latest understanding of pathogenesis and treatment options. Nat Rev Endocrinol 20(11):647\u2013660","journal-title":"Nat Rev Endocrinol"},{"key":"10540_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.695736","volume":"8","author":"B Li","year":"2021","unstructured":"Li B, Li Z, Huang Y (2021) Investigating changes in cardiac function and structure of left ventricle by speckle-tracking echocardiography in patients with hyperthyroidism and Graves\u2019 disease. Front Cardiovasc Med 8:695736","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"10540_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100699","volume":"3","author":"Z Li","year":"2022","unstructured":"Li Z, Wang M, Tan J et al (2022) Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy. Cell Rep Med 3(8):100699","journal-title":"Cell Rep Med"},{"issue":"6","key":"10540_CR37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1089\/thy.2018.0318","volume":"29","author":"S Malmstroem","year":"2019","unstructured":"Malmstroem S, Grove-Laugesen D, Riis AL (2019) Muscle performance and postural stability are reduced in patients with newly diagnosed Graves\u2019 disease. Thyroid 29(6):783\u2013789","journal-title":"Thyroid"},{"issue":"12","key":"10540_CR39","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1089\/thy.2011.0209","volume":"21","author":"SM McLachlan","year":"2011","unstructured":"McLachlan SM, Alpi K, Rapoport B (2011) Review and hypothesis: Does Graves\u2019 disease develop in non-human great apes? Thyroid 21(12):1359\u20131366","journal-title":"Thyroid"},{"key":"10540_CR38","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1210\/er.2004-0023","volume":"26","author":"SM McLachlan","year":"2005","unstructured":"McLachlan SM, Nagayama Y, Rapoport B (2005) Insight into Graves\u2019 hyperthyroidism from animal models. Endocr Rev 26:800\u2013832","journal-title":"Endocr Rev"},{"key":"10540_CR40","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1210\/jc.2008-2134","volume":"94","author":"Y Mizutori","year":"2009","unstructured":"Mizutori Y, Chen CR, Latrofa F et al (2009) Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves\u2019 disease. J Clin Endocr Metab 94:927\u2013935","journal-title":"J Clin Endocr Metab"},{"issue":"2","key":"10540_CR41","first-page":"92","volume":"63","author":"J Mysliwiec","year":"2012","unstructured":"Mysliwiec J, Palyga I, Nikolajuk A et al (2012) Serum interleukin-16 and RANTES during treatment of Graves\u2019 orbitopathy with corticosteroids and teleradiotherapy. Endokrynol Pol 63(2):92\u201396","journal-title":"Endokrynol Pol"},{"key":"10540_CR43","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.4049\/jimmunol.168.6.2789","volume":"168","author":"Y Nagayama","year":"2002","unstructured":"Nagayama Y, Kita-Furuyama M, Ando T et al (2002) A novel murine model of Graves\u2019 hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor. J Immunol 168:2789\u20132794","journal-title":"J Immunol"},{"key":"10540_CR42","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1172\/JCI115297","volume":"88","author":"Y Nagayama","year":"1991","unstructured":"Nagayama Y, Wadsworth HL, Russo D et al (1991) Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin\/ chorionic gonadotropin receptors. J Clin Invest 88:336\u2013340","journal-title":"J Clin Invest"},{"issue":"1","key":"10540_CR44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211628","volume":"220","author":"A Nakayama","year":"2023","unstructured":"Nakayama A, Roquid KA, Iring A et al (2023) Suppression of CCL2 angiocrine function by adrenomedullin promotes tumor growth. J Exp Med 220(1):e20211628","journal-title":"J Exp Med"},{"key":"10540_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nri3544","volume":"13","author":"RJ Nibbs","year":"2013","unstructured":"Nibbs RJ, Graham GJ (2013) Immune regulation by atypical chemokine receptors. Nat Rev Immunol 13:815\u2013829","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10540_CR46","doi-asserted-by":"publisher","first-page":"924","DOI":"10.4158\/EP12002.OR","volume":"18","author":"SA Price","year":"2012","unstructured":"Price SA, Thondam S, Bondugulapati LNR et al (2012) Significant attenuation of stimulated cortisol in early Graves\u2019 disease without adrenal autoimmunity. Endocr Pract 18(6):924\u2013930","journal-title":"Endocr Pract"},{"issue":"7783","key":"10540_CR47","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran P, Dobie R, Wilson-Kanamori JR et al (2019) Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575(7783):512\u2013518","journal-title":"Nature"},{"key":"10540_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1034374","volume":"13","author":"M Rao","year":"2022","unstructured":"Rao M, Wang Y, Ren J et al (2022) Effect of 131I with and without artificial liver support system in patients with Graves\u2019 disease and severe liver dysfunction: a retrospective study. Front Endocrinol (Lausanne) 13:1034374","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10540_CR50","doi-asserted-by":"publisher","first-page":"E871","DOI":"10.1210\/jc.2015-1528","volume":"100","author":"B Rapoport","year":"2015","unstructured":"Rapoport B, Aliesky HA, Chen CR et al (2015) Evidence that TSH receptor A-subunit multimers, not monomers, drive antibody affinity maturation in Graves\u2019 disease. J Clin Endocrinol Metab 100:E871\u2013E875","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10540_CR49","first-page":"673","volume":"19","author":"B Rapoport","year":"1998","unstructured":"Rapoport B, Chazenbalk GD, Jaume JC et al (1998) The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19(6):673\u2013716","journal-title":"Endocr Rev"},{"issue":"6","key":"10540_CR51","doi-asserted-by":"publisher","first-page":"E1067","DOI":"10.1152\/ajpendo.00253.2004","volume":"288","author":"ALD Riis","year":"2005","unstructured":"Riis ALD, J\u00f8rgensen JOL, Gjedde S et al (2005) Whole body and forearm substrate metabolism in hyperthyroidism: evidence of increased basal muscle protein breakdown. Am J Physiol Endocrinol Metab 288(6):E1067-1073","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10540_CR52","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS et al (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343\u20131421","journal-title":"Thyroid"},{"issue":"8","key":"10540_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fendo.2017.00119","volume":"2","author":"D Santoro","year":"2017","unstructured":"Santoro D, Vadal\u00e0 C, Siligato R et al (2017) Autoimmune thyroiditis and glomerulopathies. Front Endocrinol 2(8):119","journal-title":"Front Endocrinol"},{"issue":"1","key":"10540_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s13730-013-0093-y","volume":"3","author":"K Sasaki","year":"2014","unstructured":"Sasaki K, Yasuda K, Nakanishi K et al (2014) Membranous nephropathy secondary to Graves\u2019 disease with deposits of thyroid peroxidase in an adult. CEN Case Rep 3(1):90\u201393","journal-title":"CEN Case Rep"},{"issue":"3","key":"10540_CR55","first-page":"516","volume":"27","author":"JM Scheiff","year":"1977","unstructured":"Scheiff JM, Cordier AC, Haumont S (1977) Epithelial cell proliferation in thymic hyperplasia induced by triiodothyronine. Clin Exp Immunol 27(3):516\u2013521","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10540_CR56","first-page":"1858","volume":"119","author":"E Seki","year":"2009","unstructured":"Seki E, Minicis SD, Gwak GY et al (2009) CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 119(7):1858\u20131870","journal-title":"J Clin Invest"},{"key":"10540_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812431","volume":"13","author":"S She","year":"2022","unstructured":"She S, Ren L, Chen P et al (2022) Functional roles of chemokine receptor CCR2 and its ligands in liver disease. Front Immunol 13:812431","journal-title":"Front Immunol"},{"issue":"16","key":"10540_CR58","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L (2016) Graves\u2019 disease. N Engl J Med 375(16):1552\u20131565","journal-title":"N Engl J Med"},{"issue":"4","key":"10540_CR59","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s11259-023-10133-x","volume":"47","author":"N Su","year":"2023","unstructured":"Su N, Lin Z, Liu X et al (2023) Pathological observation and transcriptomic analysis of thymus injury in PRRSV-infected piglets. Vet Res Commun 47(4):1949\u20131962","journal-title":"Vet Res Commun"},{"issue":"4","key":"10540_CR60","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1002\/hep.23800","volume":"52","author":"L Tian","year":"2010","unstructured":"Tian L, Song Y, Xing M et al (2010) A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3 - hydroxy - 3 - methyl - glutaryl - coenzyme A reductase expression through the cyclic adenosine monophosphate\/protein kinase A\/cyclic adenosine monophosphate-responsive element binding protein pathway. Hepatology 52(4):1401\u20131409","journal-title":"Hepatology"},{"key":"10540_CR61","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/hep.20085","volume":"39","author":"G Upadhyay","year":"2004","unstructured":"Upadhyay G, Singh R, Kumar A et al (2004) Severe hyperthyroidism induces mitochondria-mediated apoptosis in rat liver. Hepatology 39:1120\u20131130","journal-title":"Hepatology"},{"issue":"6","key":"10540_CR62","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1089\/thy.2013.0396","volume":"24","author":"K van der Weerd","year":"2014","unstructured":"van der Weerd K, van Hagen PM, Schrijver B et al (2014) Thyrotropin acts as a T-cell developmental factor in mice and humans. Thyroid 24(6):1051\u20131061","journal-title":"Thyroid"},{"issue":"5","key":"10540_CR63","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/jgh3.12337","volume":"4","author":"B Wafa","year":"2020","unstructured":"Wafa B, Faten H, Mouna E et al (2020) Hyperthyroidism and hepatic dysfunction: report of 17 cases. JGH Open 4(5):876\u2013879","journal-title":"JGH Open"},{"issue":"4","key":"10540_CR64","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S2213-8587(23)00005-0","volume":"11","author":"WM Wiersinga","year":"2023","unstructured":"Wiersinga WM, Poppe KG, Effraimidis G (2023) Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol 11(4):282\u2013298","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"10540_CR65","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jhep.2014.06.037","volume":"61","author":"F Yan","year":"2014","unstructured":"Yan F, Wang Q, Lu M et al (2014) Thyrotropin increases hepatic triglyceride content through upregulation of SREBP\u20141c activity. J Hepatol 61(6):1358\u20131364","journal-title":"J Hepatol"},{"key":"10540_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.975367","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yang K, Chen F et al (2022b) Role of the CCL2-CCR2 axis in cardiovascular disease: pathogenesis and clinical implications. Front Immunol 13:975367","journal-title":"Front Immunol"},{"key":"10540_CR66","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41467-022-28120-2","volume":"13","author":"QY Zhang","year":"2022","unstructured":"Zhang QY, Ye XP, Zhou Z et al (2022a) Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto\u2019s thyroiditis. Nat Commun 13:775","journal-title":"Nat Commun"},{"issue":"4","key":"10540_CR68","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/CIRCULATIONAHA.121.056730","volume":"146","author":"H Zhu","year":"2022","unstructured":"Zhu H, Galdos FX, Lee D et al (2022) Identification of pathogenic immune cell subsets associated with checkpoint inhibitor-induced myocarditis. Circulation 146(4):316\u2013335","journal-title":"Circulation"},{"issue":"9","key":"10540_CR69","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.eprac.2024.05.010","volume":"30","author":"JVR Zuntini","year":"2024","unstructured":"Zuntini JVR, Atala YB, Parisi MCR et al (2024) Cardiac autonomic neuropathy in Graves\u2019 disease: smoking and age as predictive factors. Endocr Pract 30(9):822\u2013829","journal-title":"Endocr Pract"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10540-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T06:02:43Z","timestamp":1763791363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10540-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10540"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10540-1","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"type":"print","value":"1567-2379"},{"type":"electronic","value":"1567-2387"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"5 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal care procedures and treatments were performed according to the Guide for the Care and Use of Laboratory Animals and were approved by the local authorities at Lanzhou University Second Hospital, China. This study was performed in line with the principles of the Declaration of Helsinki. The institutional review board at Lanzhou University Second Hospital approved the study protocol.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"368"}}